Genovate Biotechnology Co Ltd (4130) — Free Cash Flow Generation Index
Genovate Biotechnology Co Ltd (4130) has a Free Cash Flow Generation Index of 0.52x as of December 2025. Free cash flow of NT$8.74 Million represents 1% of operating cash flow (NT$16.93 Million). Read 4130 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Genovate Biotechnology Co Ltd Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Genovate Biotechnology Co Ltd across 10 annual periods. Explore 4130 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Genovate Biotechnology Co Ltd (2015–2025)
Year-by-year Free Cash Flow Generation Index for Genovate Biotechnology Co Ltd. For the full company profile including market capitalisation, see 4130 market cap overview.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.40x | NT$-17.63 Million | NT$43.79 Million | NT$61.42 Million | ▼ -193.4% |
| 2024 | 0.43x | NT$23.74 Million | NT$55.11 Million | NT$31.37 Million | ▼ -29.0% |
| 2023 | 0.61x | NT$51.44 Million | NT$84.78 Million | NT$33.34 Million | ▲ +104.1% |
| 2022 | -14.90x | NT$-22.50 Million | NT$1.51 Million | NT$24.01 Million | ▼ -2265.8% |
| 2020 | 0.69x | NT$59.92 Million | NT$87.08 Million | NT$27.01 Million | ▲ +91.5% |
| 2019 | 0.36x | NT$15.96 Million | NT$44.43 Million | NT$25.76 Million | ▼ -13.3% |
| 2018 | 0.41x | NT$26.07 Million | NT$62.88 Million | NT$35.26 Million | ▲ +276.5% |
| 2017 | -0.23x | NT$-7.34 Million | NT$31.27 Million | NT$38.53 Million | ▼ -114.9% |
| 2016 | 1.58x | NT$111.45 Million | NT$70.58 Million | NT$40.87 Million | ▼ -40.5% |
| 2015 | 2.65x | NT$86.28 Million | NT$32.53 Million | NT$53.75 Million | — |